Artificial Kidney, Artificial Liver, and Artificial Cells

  • Thomas Ming Swi Chang

Table of contents

  1. Front Matter
    Pages i-x
  2. Address of Welcome

    1. L. Yaffe
      Pages 1-1
  3. Introduction

    1. T. M. S. Chang
      Pages 3-8
  4. Reviews of Hemodialysis, Dialysate Regeneration, Hemofiltration and Oxystarch

    1. Front Matter
      Pages 9-9
    2. Arthur Gordon, Andrew J. Lewin, Morton H. Maxwell, Martin Roberts
      Pages 23-32
    3. Eli A. Friedman, James T. Hutchisson, Robert S. Galonsky, Richard L. Hessert
      Pages 33-38
    4. Lee W. Henderson
      Pages 39-46
  5. Microencapsulated Adsorbent Hemoperfusion

    1. Front Matter
      Pages 55-55
    2. Michio Odaka, Yoichiro Tabata, Hirotada Kobayashi, Yoichi Nomura, Hiromitsu Soma, Hiroyuki Hirasawa et al.
      Pages 79-88
    3. I. Amano, H. Kano, H. Takahira, Y. Yamamoto, K. Itoh, S. Iwatsuki et al.
      Pages 89-98
    4. James F. Winchester
      Pages 107-116
    5. A. M. Martin, J. K. Gibbins, A. Oduro, R. Herbert
      Pages 143-151
    6. R. Oulès, H. Asaba, M. Neuhäuser, V. Yahiel, S. Bæhrendtz, B. Gunnarsson et al.
      Pages 153-164

About this book


There is a rapid increase in interest related to novel approaches in artificial kidneys, artificial liver, and detoxifi­ cation. Recent research has included the successful clinical appli­ cations of the principle of artificial cells for adsorbent hemo­ perfusion. Since it is 20 years ago at McGill that the first report on "Artificial Cells" was presented, I thought it might be useful to get together a small group of speakers and participants for a day before the ASAIO meeting to discuss some recent advances in the area of the clinical applications of artificial kidney, artificial liver and artificial cells with emphasis on adsorbent hemoperfusion. However, the enthusiastic supports of distinguished speakers, session chairmen and participants were such that the original pro­ jection of 100 participants had expanded to a preregistration total of 250, from Australia, Canada, England, France, Germany, Israel, Italy, Japan, The Netherlands, Scotland, Sweden and U. S. A. The program also expanded to include a review section on hemodialysis, dialysate regeneration, hemofiltration, resin hemoperfusion and oxystarch given by their respective originators. The remaining of the symposium emphasizes the status of the art on different encap­ sulated adsorbent hemoperfusion approaches. I would like to apolo­ gize to those who we could not accommodate beca~se of space limita­ tions. It is hoped that this symposium volume may be useful for them and for others who are interested in this area. Special thanks are due to Ms Joanne Toms for her excellent secretarial assistance for the conference and Mrs.


cells clinical application dialysis hemodialysis kidney liver renal failure research

Editors and affiliations

  • Thomas Ming Swi Chang
    • 1
    • 2
  1. 1.Medical Research Council of CanadaMontrealCanada
  2. 2.Artificial Organs Research Unit, Faculty of MedicineMcGill UniversityMontrealCanada

Bibliographic information

  • DOI
  • Copyright Information Springer-Verlag US 1978
  • Publisher Name Springer, Boston, MA
  • eBook Packages Springer Book Archive
  • Print ISBN 978-1-4684-2480-5
  • Online ISBN 978-1-4684-2478-2
  • About this book